Quick Answer
Ensysce Biosciences, Inc. reported Total Assets of $7.45 million for fiscal year 2025.
Ensysce Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.45M | +33.1% |
| 2024 | $5.60M | +106.7% |
| 2023 | $2.71M | -54.0% |
| 2022 | $5.89M | -64.2% |
| 2021 | $16.42M | +4566.6% |
| 2020 | $351.8K | -99.8% |
| 2019 | $196.51M | -4.1% |
| 2018 | $204.83M | +1.2% |
| 2017 | $202.43M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.18M | -66.1% | -43.0% |
| June 30, 2025 | $5.57M | +99.4% | +20.9% |
| March 31, 2025 | $4.61M | -9.1% | -17.6% |
| December 31, 2024 | $5.60M | +106.7% | -40.4% |
| September 30, 2024 | $9.38M | +191.6% | +235.7% |
| June 30, 2024 | $2.80M | -56.0% | -44.9% |
| March 31, 2024 | $5.07M | +29.6% | +87.4% |
| December 31, 2023 | $2.71M | -54.0% | -15.9% |
- Ensysce Biosciences, Inc. showed an increase of +33.1% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Ensysce Biosciences, Inc.’s total assets has declined by 96.3% (from $202.43 million to $7.45 million).
- The most recent figure is from Ensysce Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: